Advertisement

The 30-Day Readmission Rate of Same-Day Discharge Following Transcatheter Aortic Valve Implantation (from National Readmission Database 2015 to 2019)

      The length of hospital stay after transcatheter aortic valve implantation (TAVI) has decreased over the years, and next-day discharge is being increasingly adopted in clinical practice. Whether further expediting discharge after TAVI by allowing same-day discharge (SDD) in selected patients is safe or derives additional benefits remains unanswered. Using the United States Nationwide Readmission Database 2015 to 2019, we identified 196,618 patients who received TAVI (mean age 79.5 8.4 years, 45.0% female). Of these, 245 patients (0.12%) were discharged on the same day they received TAVI (SDD group), and the remaining 196,373 were discharged on a different day (different-day discharge [DDD] group). A propensity score–matched analysis was done. The rate of unplanned readmission within 30 days of discharge was not significantly different between the SDD and DDD groups (11.0% vs 10.6%, hazard ratio 1.03, 95% confidence interval 0.56 to 1.90, p = 0.921). Hospitalization costs were significantly lower in the SDD group than the DDD group ($37,811 ± 18,029 vs $49,130 ± 27,007, p <0.001). In conclusion, the 30-day readmission rate was similar for patients discharged on the same day after TAVI and for patients discharged at a later time point.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Members Writing Committee
        • CM Otto
        • Nishimura RA
        • Bonow RO
        • Carabello BA
        • Erwin III, JP
        • Gentile F
        • Jneid H
        • Krieger EV
        • Mack M
        • McLeod C
        ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2021; 77: e25-e197
        • Thourani VH
        • Kodali S
        • Makkar RR
        • Herrmann HC
        • Williams M
        • Babaliaros V
        • Smalling R
        • Lim S
        • Malaisrie SC
        • Kapadia S
        • Szeto WY
        • Greason KL
        • Kereiakes D
        • Ailawadi G
        • Whisenant BK
        • Devireddy C
        • Leipsic J
        • Hahn RT
        • Pibarot P
        • Weissman NJ
        • Jaber WA
        • Cohen DJ
        • Suri R
        • Tuzcu EM
        • Svensson LG
        • Webb JG
        • Moses JW
        • Mack MJ
        • Miller DC
        • Smith CR
        • Alu MC
        • Parvataneni R
        • D'Agostino RB
        • Leon MB
        Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
        Lancet. 2016; 387: 2218-2225
        • Reardon MJ
        • Van Mieghem NM
        • Popma JJ
        • Kleiman NS
        • Søndergaard L
        • Mumtaz M
        • Adams DH
        • Deeb GM
        • Maini B
        • Gada H
        • Chetcuti S
        • Gleason T
        • Heiser J
        • Lange R
        • Merhi W
        • Oh JK
        • Olsen PS
        • Piazza N
        • Williams M
        • Windecker S
        • Yakubov SJ
        • Grube E
        • Makkar R
        • Lee JS
        • Conte J
        • Vang E
        • Nguyen H
        • Chang Y
        • Mugglin AS
        • Serruys PW
        • Kappetein AP
        • SURTAVI Investigators
        Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.
        N Engl J Med. 2017; 376: 1321-1331
        • Kotronias RA
        • Teitelbaum M
        • Webb JG
        • Mylotte D
        • Barbanti M
        • Wood DA
        • Ballantyne B
        • Osborne A
        • Solo K
        • Kwok CS
        • Mamas MA
        • Bagur R.
        Early versus standard discharge after transcatheter aortic valve replacement: a systematic review and meta-analysis.
        JACC Cardiovasc Interv. 2018; 11: 1759-1771
        • Kamioka N
        • Wells J
        • Keegan P
        • Lerakis S
        • Binongo J
        • Corrigan F
        • Condado J
        • Patel A
        • Forcillo J
        • Ogburn L
        • Dong A
        • Caughron H
        • Simone A
        • Leshnower B
        • Devireddy C
        • Mavromatis K
        • Guyton R
        • Stewart J
        • Thourani V
        • Block PC
        • Babaliaros V.
        Predictors and clinical outcomes of next-day discharge after minimalist transfemoral transcatheter aortic valve replacement.
        JACC Cardiovasc Interv. 2018; 11: 107-115
        • Wood DA
        • Lauck SB
        • Cairns JA
        • Humphries KH
        • Cook R
        • Welsh R
        • Leipsic J
        • Genereux P
        • Moss R
        • Jue J
        • Blanke P
        • Cheung A
        • Ye J
        • Dvir D
        • Umedaly H
        • Klein R
        • Rondi K
        • Poulter R
        • Stub D
        • Barbanti M
        • Fahmy P
        • Htun N
        • Murdoch D
        • Prakash R
        • Barker M
        • Nickel K
        • Thakkar J
        • Sathananthan J
        • Tyrell B
        • Al-Qoofi F
        • Velianou JL
        • Natarajan MK
        • Wijeysundera HC
        • Radhakrishnan S
        • Horlick E
        • Osten M
        • Buller C
        • Peterson M
        • Asgar A
        • Palisaitis D
        • Masson JB
        • Kodali S
        • Nazif T
        • Thourani V
        • Babaliaros VC
        • Cohen DJ
        • Park JE
        • Leon MB
        • Webb JG.
        The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study.
        JACC Cardiovasc Interv. 2019; 12: 459-469
        • Barbanti M
        • van Mourik MS
        • Spence MS
        • Iacovelli F
        • Martinelli GL
        • Muir DF
        • Saia F
        • Bortone AS
        • Densem CG
        • van der Kley F
        • Bramlage P
        • Vis M
        • Tamburino C.
        Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial.
        EuroIntervention. 2019; 15: 147-154
        • Costa G
        • Barbanti M
        • Picci A
        • Todaro D
        • La Spina K
        • Di Simone E
        • D'Arrigo P
        • Criscione E
        • Valvo R
        • Reddavid C
        • Deste W
        • Sgroi C
        • Tamburino C
        • Giuffrida A
        • Garretto V
        • Privitera G
        • Cannizzaro MT
        • Inserra C
        • Veroux P
        Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation.
        EuroIntervention. 2020; 16: e494-e501
        • Généreux P
        • Demers P
        • Poulin F.
        Same day discharge after transcatheter aortic valve replacement: are we there yet?.
        Catheter Cardiovasc Interv. 2016; 87: 980-982
        • Williams PD
        • Vijayan S
        • McCalmont G
        • Muir D.
        Daycase transcatheter aortic valve replacement: preliminary experience.
        JACC Cardiovasc Interv. 2020; 13: 1838-1841
        • Zouaghi O
        • Wintzer-Wehekind J
        • Lienhart Y
        • Abdellaoui M
        • Faurie B.
        Ambulatory TAVR: early feasibility experience during the COVID-19 pandemic.
        CJC Open. 2020; 2: 729-731
        • Rai D
        • Tahir MW
        • Chowdhury M
        • Ali H
        • Buttar R
        • Abtahian F
        • Bhatt DL
        • Depta JP.
        Transcatheter aortic valve replacement same-day discharge for selected patients: a case series.
        Eur Heart J Case Rep. 2021; 5: ytaa556
        • Russo MJ
        • Okoh AK
        • Stump K
        • Smith M
        • Erinne I
        • Johannesen J
        • Chaudhary A
        • Chiricolo A
        • Hakeem A
        • Lemaire A
        • Lee LY
        • Chen C.
        Safety and feasibility of same day discharge after transcatheter aortic valve replacement post COVID-19.
        Struct Heart. 2021; 5: 182-185
        • Perdoncin E
        • Greenbaum AB
        • Grubb KJ
        • Babaliaros VC
        • Keegan P
        • Ceretto-Clark B
        • Wei J
        • Guyton RA
        • Paone G
        • Byku I
        • Gleason PT
        • Biven K
        • Mathew P
        • Mortorano C
        • Inci EK
        • Faaborg-Andersen C
        • Mitchell R
        • Devireddy CM.
        Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.
        Catheter Cardiovasc Interv. 2021; 97: 940-947
        • Okoh AK
        • Russo M
        • Patel K
        • Hakeem A
        • Soliman F
        • Haik B
        • Chiricolo A
        • Lee L
        • Chen C.
        Same-day discharge after transcatheter aortic valve replacement during the COVID-19 pandemic.
        J Am Coll Cardiol. 2021; 77: 3102
        • Pop AM
        • Barker M
        • Hickman L
        • Barrow F
        • Sathananthan J
        • Stansfield W
        • Nikolov M
        • Mohamed E
        • Lauck S
        • Wang J
        • Webb JG
        • Wood DA
        Same day discharge during the COVID-19 pandemic in highly selected transcatheter aortic valve replacement patients.
        Struct Heart. 2021; 5: 596-604
      1. AHRQ. Overview of the nationwide readmissions database (NRD). Available at: http://www.hcup-us.ahrq.gov/nrdoverview.jsp. Accessed on April 1, 2022.

      2. AHRQ. Cost-to-charge ratio for inpatient files. Available at: http://www.hcup-us.ahrq.gov/db/ccr/ip-ccr/ip-ccr.jsp. Accessed on April 1, 2022.

      3. AHRQ. Cost-to-charge ratios for emergency department files. Available at:http://www.hcup-us.ahrq.gov/db/ccr/ed-ccr/ed-ccr.jsp. Accessed on April 1, 2022.

        • Knottnerus A
        • Tugwell P.
        STROBE–a checklist to strengthen the reporting of observational studies in epidemiology.
        J Clin Epidemiol. 2008; 61: 323
        • Griswold ME
        • Localio AR
        • Mulrow C.
        Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias.
        Ann Intern Med. 2010; 152: 393-395
        • Kolte D
        • Kennedy K
        • Wasfy JH
        • Jena AB
        • Elmariah S.
        Hospital variation in 30-day readmissions following transcatheter aortic valve replacement.
        J Am Heart Assoc. 2021; 10e021350